Have a feature idea you'd love to see implemented?
Let us know!
CELC Celcuity Inc
Price (delayed)
$12.73
Market cap
$472.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.6
Enterprise value
$557.25M
Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia,
Highlights
The company's EPS rose by 4.8% QoQ and by 4.8% YoY
The equity has soared by 61% YoY but it has contracted by 15% from the previous quarter
The debt has soared by 163% YoY
CELC's net income has plunged by 66% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of CELC
Market
Valuations
Earnings
Shares outstanding
37.13M
Market cap
$472.66M
Enterprise value
$557.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$85.57M
EBITDA
-$85.45M
Free cash flow
-$74.47M
Per share
Balance sheet
Liquidity
EPS
-$2.6
Free cash flow per share
-$1.74
Book value per share
$4.04
Revenue per share
$0
TBVPS
$6.38
Total assets
$273.04M
Total liabilities
$123.33M
Debt
$97.19M
Equity
$149.71M
Working capital
$246.13M
Debt to equity
0.65
Current ratio
10.36
Quick ratio
10.04
Net debt/EBITDA
-0.99
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.8%
Return on equity
-62.7%
Return on invested capital
-33.2%
Return on capital employed
-34.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELC stock price
How has the Celcuity stock price performed over time
Intraday
-0.39%
1 week
-9.78%
1 month
-21.08%
1 year
-1.32%
YTD
-12.63%
QTD
-14.62%
Financial performance
How have Celcuity's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$96.57M
Net income
-$93.97M
Gross margin
N/A
Net margin
N/A
CELC's net income has plunged by 66% YoY and by 14% from the previous quarter
The operating income has dropped by 66% year-on-year and by 13% since the previous quarter
Growth
What is Celcuity's growth rate over time
Valuation
What is Celcuity stock price valuation
P/E
N/A
P/B
3.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 4.8% QoQ and by 4.8% YoY
The equity has soared by 61% YoY but it has contracted by 15% from the previous quarter
CELC's price to book (P/B) is 19% less than its 5-year quarterly average of 3.9 and 10% less than its last 4 quarters average of 3.5
Efficiency
How efficient is Celcuity business performance
The ROE has decreased by 28% YoY and by 3.1% from the previous quarter
The return on assets has declined by 12% year-on-year
Celcuity's return on invested capital has increased by 8% QoQ
Dividends
What is CELC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELC.
Financial health
How did Celcuity financials performed over time
Celcuity's total assets is 121% more than its total liabilities
CELC's total liabilities has surged by 149% year-on-year and by 6% since the previous quarter
Celcuity's total assets has soared by 92% YoY but it has decreased by 7% from the previous quarter
The debt is 35% less than the equity
The debt has soared by 163% YoY
The company's debt to equity has surged by 63% YoY and by 18% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.